SARS CoV 2 News and Research

RSS

Factors that increase the risk of severe COVID-19 in children

Study analyzes a nationwide cohort of hospitalized children and adolescents in Germany, identifying key risk factors for severe SARS-CoV-2 infection, including obesity, Trisomy 21, and neurological conditions.

3 Jan 2024

Are pan-coronavirus vaccines an achievable goal in providing broad protection against human coronaviruses?

The current achievements in the development of a pan-coronavirus vaccine.

3 Jan 2024

Hybrid immunity's role in curbing COVID-19: Canadian study sheds light on vaccine-infection synergy

Study evaluates the impact of hybrid immunity on SARS-CoV-2 antibody levels in Canadian adults, revealing that hybrid immunity, combining vaccination and recovery from infection, significantly reduces COVID-19 morbidity and mortality.

2 Jan 2024

New Pfizer/BioNTech vaccine variant shows enhanced protection against COVID-19 hospitalization

Study demonstrates that the BNT162b2 SARS-CoV-2 XBB1.5 variant-modified vaccine significantly reduces the risk of COVID-19-related hospitalizations and ambulatory visits, outperforming previous vaccine versions in the face of evolving virus strains.

2 Jan 2024

AI tool tracks mutations to predict next COVID variant wave

An AI model can predict which SARS-CoV-2 variants are likely to cause new waves of infection. Current models used to predict the dynamics of viral transmission do not predict variant-specific spread.

2 Jan 2024

New non-steroidal anti-inflammatory can inhibit the cytokine storm and preserve innate immunity

Very early in the COVID-19 pandemic clinical trials in patients hospitalized with COVID-19 confirmed that corticosteroids like dexamethasone reduced mortality, but they were harmful when applied at the first COVID-19 symptoms, due to the weakening of innate antiviral immunity, leading to delayed viral clearance and adverse outcomes in severe viral pneumonias.

28 Dec 2023

New vaccine design targets universal immunity with "chef"-inspired tool

Vaccine development aims at protecting as many people as possible from infections. Short protein fragments of pathogens, so-called epitopes, are seen as a promising new approach for vaccine development.

20 Dec 2023

NHS COVID-19 app study shows digital contact tracing's effectiveness in predicting virus transmission risks

A comprehensive study in the Nature journal analyzed over seven million data points from the NHS COVID-19 app, revealing how digital contact tracing can effectively predict SARS-CoV-2 transmission risks based on exposure duration and proximity.

20 Dec 2023

First case of COVID-caused vocal cord paralysis in teen reported by Mass Eye and Ear doctors

Physician-researchers from Mass Eye and Ear, a member of Mass General Brigham, report the first pediatric case of bilateral vocal cord paralysis after COVID-19 (SARS-CoV-2) infection.

19 Dec 2023

T-cells step up to offer protection against COVID-19 in B-cell deficient patients

B cell deficiency is a common condition that can result either from immunosuppressant drugs used to treat autoimmune disease or certain cancers - such as rituximab (RTX) - or from natural immune deficiency.

18 Dec 2023

New vaccine strategy targets SARS-CoV-2's stable S2 subunit, offering broad protection against evolving variants

Study presents a new SARS-CoV-2 S2 subunit vaccine that elicits strong antibody responses against various sarbecovirus strains, including challenging variants like XBB.1.5, demonstrating its potential as a broadly effective and stable vaccine option.

18 Dec 2023

New Year's Eve celebrations linked to spike in COVID-19 cases: Small gatherings, not large events, the main culprit

Study investigates the impact of New Year's Eve celebrations on SARS-CoV-2 transmission in Belgium, revealing that small-scale social gatherings, rather than large events, significantly contributed to a surge in COVID-19 cases among higher education students.

18 Dec 2023

COVID-19 hospitalization linked to greater long-term health risks than seasonal influenza

Study reveals that hospitalized COVID-19 patients face higher long-term risks of death and health adversities across multiple organ systems compared to those hospitalized with seasonal influenza.

18 Dec 2023

Antibody treatment shields transplant patients against COVID-19

New research from Cedars-Sinai's Comprehensive Transplant Center found that a monoclonal antibody treatment reduced the risk of COVID-19 in a large group of solid organ transplant patients who were administered the drug as a preventive measure against the disease.

18 Dec 2023

Experts from leading institutions launch Pandemic Research Alliance for collaborative virus defense

World-renowned professors from six leading institutions in four countries launched the Pandemic Research Alliance (PRA) today (4 December) to drive concerted research into respiratory viruses from animals to humans, improved surveillance, and new solutions to better manage the next pandemic.

17 Dec 2023

Study sheds light on global laboratory-acquired infections and pathogen escapes

Study analyzes global incidents of laboratory-acquired infections and accidental pathogen escapes from 2000 to 2021, highlighting the need for improved biosafety protocols and reporting systems.

17 Dec 2023

Study links omicron's cellular senescence to inflammation and long-COVID risk

A new research paper was published on the cover of Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 23, entitled, "Uncovering a unique pathogenic mechanism of SARS-CoV-2 omicron variant: selective induction of cellular senescence."

15 Dec 2023

SARS CoV 2 News and Research

Factors that increase the risk of severe COVID-19 in children

Are pan-coronavirus vaccines an achievable goal in providing broad protection against human coronaviruses?

Hybrid immunity's role in curbing COVID-19: Canadian study sheds light on vaccine-infection synergy

New Pfizer/BioNTech vaccine variant shows enhanced protection against COVID-19 hospitalization

AI tool tracks mutations to predict next COVID variant wave

New non-steroidal anti-inflammatory can inhibit the cytokine storm and preserve innate immunity

New vaccine design targets universal immunity with "chef"-inspired tool

NHS COVID-19 app study shows digital contact tracing's effectiveness in predicting virus transmission risks

First case of COVID-caused vocal cord paralysis in teen reported by Mass Eye and Ear doctors

T-cells step up to offer protection against COVID-19 in B-cell deficient patients

New vaccine strategy targets SARS-CoV-2's stable S2 subunit, offering broad protection against evolving variants

New Year's Eve celebrations linked to spike in COVID-19 cases: Small gatherings, not large events, the main culprit

COVID-19 hospitalization linked to greater long-term health risks than seasonal influenza

Antibody treatment shields transplant patients against COVID-19

Experts from leading institutions launch Pandemic Research Alliance for collaborative virus defense

Study sheds light on global laboratory-acquired infections and pathogen escapes

Study links omicron's cellular senescence to inflammation and long-COVID risk

Novel immunization strategies can markedly increase mucosal immunity in nonhuman primates

Alzheimer's may worsen COVID-19 outcomes via olfactory mucosa changes

New study reveals how travel patterns shaped COVID-19 transmission

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News